Is tolvaptan indicated for refractory oedema in nephrotic syndrome?
Author:
Affiliation:
1. Department of Internal Medicine; Hanyang University College of Medicine; Seoul South Korea
Publisher
Wiley
Subject
Nephrology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/nep.12348/fullpdf
Reference17 articles.
1. Potent aquaretic agent: a novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men;Ohnishi;J. Clin. Invest.,1993
2. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure;Costello-Boerrigter;Am. J. Physiol. Renal Physiol.,2006
3. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials;Gheorghiade;JAMA,2007
4. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial;Gerbes;Gastroenterology,2003
5. Tolvaptan therapy for massive edema in a patient with nephrotic syndrome;Shimizu;Pediatr. Nephrol.,2014
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tolvaptan therapy for edema in patients with chronic kidney disease;Clinical Nephrology;2024-06-01
2. Proteasuria: The Link between Physiopathogenesis and Edema Management in Nephrotic Syndrome?;Novel Topics in the Diagnosis, Treatment, and Follow-Up of Nephritis, Nephrotic Syndrome, and Nephrosis [Working Title];2022-11-10
3. Efficacy and Safety of Combination Therapy with Tolvaptan and Furosemide in Children with Nephrotic Syndrome and Refractory Edema: A Prospective Interventional Study;Indian Journal of Pediatrics;2022-01-26
4. Pathogenesis and Treatment of Refractory Oedema in Nephrotic Syndrome;EMJ Urology;2021-08-23
5. Mechanisms and management of edema in pediatric nephrotic syndrome;Pediatric Nephrology;2020-11-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3